Palivizumab for children with Down syndrome: is the time right for a universal recommendation? | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Editorial

Palivizumab for children with Down syndrome: is the time right for a universal recommendation?

Online download statistics by month:

Online download statistics by month: December 2018 to November 2020

	Abstract	Full	Pdf
Dec 2018	730	48	21
Jan 2019	2474	124	91
Feb 2019	300	23	16
Mar 2019	256	15	12
Apr 2019	235	9	7
May 2019	212	11	7
Jun 2019	195	6	4
Jul 2019	741	112	53
Aug 2019	299	68	38
Sep 2019	117	41	20
Oct 2019	108	18	13
Nov 2019	98	7	8
Dec 2019	76	10	5
Jan 2020	109	9	5
Feb 2020	104	11	8
Mar 2020	45	2	1
Apr 2020	64	3	3
May 2020	37	3	1
Jun 2020	71	3	4
Jul 2020	62	0	3
Aug 2020	28	2	5
Sep 2020	110	4	3
Oct 2020	84	2	1
Nov 2020	75	6	4
Total	6630	537	333